US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ACRES Commercial Realty Corp.

18.82

-0.1100-0.58%

Post-market: 18.820.00000.00%16:10 EDT

Volume:18.36K

Turnover:345.17K

Market Cap:134.21M

PE:627.35

High:19.06

Open:18.82

Low:18.70

Close:18.93

52wk High:24.61

52wk Low:16.51

Shares:7.13M

Float Shares:7.13M

Volume Ratio:0.57

T/O Rate:0.26%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.0300

EPS(LYR):0.0300

ROE:5.59%

ROA:1.38%

PB:0.32

PE(LYR):627.35

Loading ...

Overview Company News Filings

ACRES Commercial Realty Corp. price target raised to $24.50 from $23.50 at Citizens JMP

ACRES Realty Q3 2025 Earnings Call Summary and Q&A Highlights: Strategic Asset Sales and Book Value Growth

ACRES Realty (ACR) Earnings Call Transcript

Motley Fool Transcribing

ACRES Commercial Realty Q3 Sales $21.037M Miss $22.151M Estimate.

Acres Commercial Realty reports Q3 net income of $9.8 million

Acres Commercial Realty Corp - Reports $9.8 Mln Net Income, $1.34 per Share for Q3

THOMSON REUTERS

Acres Commercial Realty Corp. Reports Results for Third Quarter 2025

THOMSON REUTERS

Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials

Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation

Enlivex Therapeutics to Present Phase IIa 3-month Data of Allocetra in Patients with Moderate-to-Severe Knee Osteoarthritis at the ACR Convergence 2025

QYUNS-B (02509): QX002N (Lusekizumab) Phase III Clinical Trial Results for Ankylosing Spondylitis Presented at 2025 ACR Annual Meeting

Acrivon Therapeutics’ Phase 1 Study of ACR-2316: Key Updates and Market Implications

Acres Commercial Realty Corp expected to post earnings of 11 cents a share - Earnings Preview

Tonix Pharmaceuticals presents data on Tonmya at ACR Convergence

Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting

Tonix Pharmaceuticals Presented Data on Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence

Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025

Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025

Fate Therapeutics Presents New Clinical Data at ACR Convergence 2025 Demonstrating Immune Remodeling and Durable Responses in Patients with Systemic Lupus Erythematosus Treated with FT819 Off-the-Shelf CAR T-Cell Therapy

Novartis showcases significant immunology advancements in ACR congress with new data in complex autoimmune diseases

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ACR/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACR\",,,,,undefined,":{"symbol":"ACR","market":"US","secType":"STK","nameCN":"ACRES Commercial Realty Corp.","latestPrice":18.82,"timestamp":1774641600000,"preClose":18.93,"halted":0,"volume":18355,"hourTrading":{"tag":"盘后","latestPrice":18.82,"preClose":18.82,"latestTime":"16:10 EDT","volume":172,"amount":3237.04,"timestamp":1774642204723,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.005810882197569965,"floatShares":7131101,"shares":7131101,"eps":0.029999,"marketStatus":"Market Closed","change":-0.11,"latestTime":"03-27 16:00:00 EDT","open":18.82,"high":19.06,"low":18.7,"amount":345173.2112,"amplitude":0.019017,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.029999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"exchange":"NYSE","adjPreClose":18.93,"postHourTrading":{"tag":"盘后","latestPrice":18.82,"preClose":18.82,"latestTime":"16:10 EDT","volume":172,"amount":3237.04,"timestamp":1774642204723,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.569861,"impliedVol":0.1687,"impliedVolPercentile":0.4502},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACR\",,,,,undefined,":{"symbol":"ACR","floatShares":7131101,"roa":"1.38%","roe":"5.59%","lyrEps":0.029999,"volumeRatio":0.569861,"shares":7131101,"dividePrice":0,"high":19.06,"amplitude":0.019017,"preClose":18.93,"low":18.7,"week52Low":16.51,"pbRate":"0.32","psRate":"1.53","week52High":24.61,"institutionHeld":0.3466,"latestPrice":18.82,"eps":0.029999,"divideRate":0,"volume":18355,"delay":0,"ttmEps":0.029999,"open":18.82,"prevYearClose":21.34,"prevWeekClose":19,"prevMonthClose":18.51,"prevQuarterClose":21.34,"fiveDayClose":19,"twentyDayClose":18.51,"sixtyDayClose":21.3,"dividendPayoutRate":1.1656236721746815,"dividendGrowthYears":0,"dividendGrowthRate":-0.7105263157894738,"fiveYearAvgDividendRate":0.07519862764902933},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-04","symbol":"ACR","fiscalQuarterEnding":"2025/12","expectedEps":-0.06,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1772600400000,"reportTimeType":"post","actualEps":-0.53},{"date":"2025-10-29","symbol":"ACR","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":null,"defaultRemindTime":1761768000000,"name":null,"time":"Post Market","dateTimestamp":1761710400000,"actualEps":null},{"market":"US","date":"2025-07-30","symbol":"ACR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"post","actualEps":-0.04},{"market":"US","date":"2025-04-30","symbol":"ACR","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1745985600000,"reportTimeType":"post","actualEps":-0.97},{"market":"US","date":"2025-03-05","symbol":"ACR","fiscalQuarterEnding":"2024/12","expectedEps":0.15,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741150800000,"reportTimeType":"post","actualEps":0.37}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACR\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-29","recordDate":"2016-03-31","paymentDate":"2016-04-28","value":0.42,"currency":"USD"},{"executeDate":"2016-06-28","recordDate":"2016-06-30","paymentDate":"2016-07-28","value":0.42,"currency":"USD"},{"executeDate":"2016-09-28","recordDate":"2016-09-30","paymentDate":"2016-10-28","value":0.42,"currency":"USD"},{"executeDate":"2016-12-28","recordDate":"2016-12-30","paymentDate":"2017-01-27","value":0.05,"currency":"USD"},{"executeDate":"2018-06-28","recordDate":"2018-06-29","paymentDate":"2018-07-27","value":0.1,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.3333,"hold":0.6667,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6667,"analysts":3,"updateTime":1765944000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACR","date":"2026-03-27","current":627.354245,"percent":0.767101,"low":-0.757992,"twenty":3.1283,"median":4.732231,"eighty":6.113163,"high":14.204017,"avg":4.978337,"sd":2.41081,"marketCap":128771608},"quantilePoints":[{"date":"2021-04-01","current":-0.728783,"twenty":-0.374023,"median":2.619904,"eighty":23.353962,"marketCap":144089825},{"date":"2021-04-09","current":-0.733571,"twenty":-0.377896,"median":2.605403,"eighty":23.351176,"marketCap":145036538},{"date":"2021-04-16","current":-0.733507,"twenty":-0.38625,"median":2.600569,"eighty":23.341486,"marketCap":145023804},{"date":"2021-04-23","current":-0.728759,"twenty":-0.394383,"median":2.571519,"eighty":23.333221,"marketCap":144085138},{"date":"2021-04-30","current":-0.716127,"twenty":-0.403156,"median":2.562972,"eighty":23.333221,"marketCap":141587548},{"date":"2021-05-07","current":12.280556,"twenty":-0.403908,"median":2.564193,"eighty":23.325539,"marketCap":145696522},{"date":"2021-05-14","current":11.159187,"twenty":-0.403156,"median":2.571519,"eighty":23.313402,"marketCap":132392591},{"date":"2021-05-21","current":12.000214,"twenty":-0.401278,"median":2.600569,"eighty":23.309699,"marketCap":142370539},{"date":"2021-05-28","current":12.008001,"twenty":-0.399569,"median":2.605403,"eighty":23.297233,"marketCap":142462928},{"date":"2021-06-04","current":12.880178,"twenty":-0.397861,"median":2.619904,"eighty":23.282034,"marketCap":152810430},{"date":"2021-06-11","current":13.61997,"twenty":-0.394449,"median":2.629572,"eighty":23.269611,"marketCap":161587329},{"date":"2021-06-18","current":13.253968,"twenty":-0.393243,"median":2.638031,"eighty":23.261298,"marketCap":157245073},{"date":"2021-06-25","current":13.191669,"twenty":-0.389358,"median":2.644073,"eighty":23.248872,"marketCap":156505966},{"date":"2021-07-02","current":12.545324,"twenty":-0.388504,"median":2.655244,"eighty":23.240563,"marketCap":148837728},{"date":"2021-07-09","current":12.958051,"twenty":-0.387002,"median":2.668242,"eighty":23.229518,"marketCap":153734314},{"date":"2021-07-16","current":12.630985,"twenty":-0.385121,"median":2.68516,"eighty":23.229518,"marketCap":149854001},{"date":"2021-07-23","current":12.919114,"twenty":-0.385121,"median":2.696036,"eighty":23.229518,"marketCap":153272372},{"date":"2021-07-30","current":13.627758,"twenty":-0.378951,"median":2.704495,"eighty":23.222589,"marketCap":161679717},{"date":"2021-08-06","current":2.692645,"twenty":-0.378071,"median":2.712954,"eighty":23.210305,"marketCap":158604894},{"date":"2021-08-13","current":2.590862,"twenty":-0.377634,"median":2.699661,"eighty":23.201855,"marketCap":152609520},{"date":"2021-08-20","current":2.612452,"twenty":-0.375728,"median":2.692528,"eighty":23.188037,"marketCap":153881266},{"date":"2021-08-27","current":2.524548,"twenty":-0.374625,"median":2.68516,"eighty":23.18112,"marketCap":148703443},{"date":"2021-09-03","current":2.529174,"twenty":-0.374625,"median":2.668242,"eighty":23.18112,"marketCap":148975960},{"date":"2021-09-10","current":2.444355,"twenty":-0.373422,"median":2.655244,"eighty":23.164533,"marketCap":143979815},{"date":"2021-09-17","current":2.424306,"twenty":-0.373121,"median":2.644073,"eighty":23.160386,"marketCap":142798908},{"date":"2021-09-24","current":2.478282,"twenty":-0.372318,"median":2.638031,"eighty":23.160386,"marketCap":145978273},{"date":"2021-10-01","current":2.530717,"twenty":-0.372,"median":2.630356,"eighty":23.160386,"marketCap":149066799},{"date":"2021-10-08","current":2.432017,"twenty":-0.36928,"median":2.624738,"eighty":23.127211,"marketCap":143253103},{"date":"2021-10-15","current":2.422764,"twenty":-0.367258,"median":2.617487,"eighty":23.118917,"marketCap":142708069},{"date":"2021-10-22","current":2.422764,"twenty":-0.362252,"median":2.608928,"eighty":23.109059,"marketCap":142708069},{"date":"2021-10-29","current":2.421222,"twenty":-0.359194,"median":2.602389,"eighty":23.099865,"marketCap":142617230},{"date":"2021-11-05","current":2.948349,"twenty":-0.357001,"median":2.601479,"eighty":23.065008,"marketCap":135081545},{"date":"2021-11-12","current":2.972158,"twenty":-0.356571,"median":2.605403,"eighty":23.045624,"marketCap":136172379},{"date":"2021-11-19","current":2.906683,"twenty":-0.355367,"median":2.614969,"eighty":23.037354,"marketCap":133172587},{"date":"2021-11-26","current":2.84716,"twenty":-0.355066,"median":2.621242,"eighty":23.035979,"marketCap":130445503},{"date":"2021-12-03","current":2.698354,"twenty":-0.354164,"median":2.629572,"eighty":23.023539,"marketCap":123627794},{"date":"2021-12-10","current":2.672561,"twenty":-0.353562,"median":2.636203,"eighty":23.015245,"marketCap":122446058},{"date":"2021-12-17","current":2.432487,"twenty":-0.351757,"median":2.629572,"eighty":23.015245,"marketCap":111446820},{"date":"2021-12-23","current":2.45828,"twenty":-0.349951,"median":2.622321,"eighty":23.001399,"marketCap":112628556},{"date":"2021-12-31","current":2.474153,"twenty":-0.348446,"median":2.614969,"eighty":22.97803,"marketCap":113355779},{"date":"2022-01-07","current":2.45828,"twenty":-0.34634,"median":2.605403,"eighty":22.973988,"marketCap":112628556},{"date":"2022-01-14","current":2.628911,"twenty":-0.344535,"median":2.605403,"eighty":22.973776,"marketCap":120446196},{"date":"2022-01-21","current":2.41463,"twenty":-0.344234,"median":2.601479,"eighty":22.969629,"marketCap":110628695},{"date":"2022-01-28","current":2.329315,"twenty":-0.342428,"median":2.593946,"eighty":22.948894,"marketCap":106719875},{"date":"2022-02-04","current":2.416614,"twenty":-0.33972,"median":2.588548,"eighty":22.928309,"marketCap":110719598},{"date":"2022-02-11","current":2.402726,"twenty":-0.338517,"median":2.584693,"eighty":22.90988,"marketCap":110083278},{"date":"2022-02-18","current":2.333283,"twenty":-0.337915,"median":2.570395,"eighty":22.898273,"marketCap":106901681},{"date":"2022-02-25","current":2.245983,"twenty":-0.335508,"median":2.564193,"eighty":22.890838,"marketCap":102901958},{"date":"2022-03-04","current":3.243244,"twenty":-0.330994,"median":2.564193,"eighty":22.871107,"marketCap":110020560},{"date":"2022-03-11","current":3.039484,"twenty":-0.330994,"median":2.570395,"eighty":22.849369,"marketCap":103108427},{"date":"2022-03-18","current":3.155514,"twenty":-0.32949,"median":2.584693,"eighty":22.828635,"marketCap":107044517},{"date":"2022-03-25","current":3.422888,"twenty":-0.32949,"median":2.588548,"eighty":22.828635,"marketCap":116114636},{"date":"2022-04-01","current":3.397664,"twenty":-0.328951,"median":2.593946,"eighty":22.827656,"marketCap":115258964},{"date":"2022-04-08","current":3.274067,"twenty":-0.327985,"median":2.601479,"eighty":22.8079,"marketCap":111066173},{"date":"2022-04-14","current":3.248843,"twenty":-0.327985,"median":2.605403,"eighty":22.791313,"marketCap":110210502},{"date":"2022-04-22","current":3.127915,"twenty":-0.327985,"median":2.612452,"eighty":22.72819,"marketCap":106108277},{"date":"2022-04-29","current":2.868089,"twenty":-0.326782,"median":2.621242,"eighty":22.688706,"marketCap":97294170},{"date":"2022-05-06","current":4.375842,"twenty":-0.326481,"median":2.628911,"eighty":22.657479,"marketCap":100429958},{"date":"2022-05-13","current":4.21343,"twenty":-0.325277,"median":2.630625,"eighty":22.634624,"marketCap":96702425},{"date":"2022-05-20","current":3.735933,"twenty":-0.322569,"median":2.636822,"eighty":22.60654,"marketCap":85743401},{"date":"2022-05-27","current":3.743573,"twenty":-0.321967,"median":2.642864,"eighty":22.591302,"marketCap":85918746},{"date":"2022-06-03","current":3.785593,"twenty":-0.321967,"median":2.651324,"eighty":22.545587,"marketCap":86883140},{"date":"2022-06-10","current":3.678634,"twenty":-0.321692,"median":2.668242,"eighty":22.48538,"marketCap":84428318},{"date":"2022-06-17","current":3.224057,"twenty":-0.320881,"median":2.67161,"eighty":22.421163,"marketCap":73995328},{"date":"2022-06-24","current":3.193497,"twenty":-0.319259,"median":2.686797,"eighty":22.367371,"marketCap":73293950},{"date":"2022-07-01","current":3.304276,"twenty":-0.317289,"median":2.691936,"eighty":22.325763,"marketCap":75836444},{"date":"2022-07-08","current":3.227877,"twenty":-0.316825,"median":2.692645,"eighty":22.317329,"marketCap":74083000},{"date":"2022-07-15","current":2.998678,"twenty":-0.315949,"median":2.699661,"eighty":22.30517,"marketCap":68822669},{"date":"2022-07-22","current":3.055978,"twenty":-0.315949,"median":2.704495,"eighty":22.284437,"marketCap":70137752},{"date":"2022-07-29","current":3.174397,"twenty":-0.315648,"median":2.716828,"eighty":22.263703,"marketCap":72855589},{"date":"2022-08-05","current":5.232925,"twenty":-0.314444,"median":2.726247,"eighty":22.238823,"marketCap":77625212},{"date":"2022-08-12","current":5.466621,"twenty":-0.314444,"median":2.760853,"eighty":22.205649,"marketCap":81091851},{"date":"2022-08-19","current":5.438471,"twenty":-0.312338,"median":2.772168,"eighty":22.201502,"marketCap":80674282},{"date":"2022-08-26","current":5.815674,"twenty":-0.303913,"median":2.785945,"eighty":22.182759,"marketCap":86269703},{"date":"2022-09-02","current":5.460991,"twenty":-0.303612,"median":2.798754,"eighty":22.174132,"marketCap":81008337},{"date":"2022-09-09","current":5.427211,"twenty":-0.302408,"median":2.815672,"eighty":22.174132,"marketCap":80507255},{"date":"2022-09-16","current":5.179496,"twenty":-0.300904,"median":2.822922,"eighty":22.164182,"marketCap":76832650},{"date":"2022-09-23","current":4.898002,"twenty":-0.300904,"median":2.831036,"eighty":22.164182,"marketCap":72656962},{"date":"2022-09-30","current":4.588358,"twenty":-0.300904,"median":2.842292,"eighty":22.164182,"marketCap":68063706},{"date":"2022-10-07","current":4.802294,"twenty":-0.300904,"median":2.861593,"eighty":22.122715,"marketCap":71237228},{"date":"2022-10-14","current":4.644657,"twenty":-0.300904,"median":2.866049,"eighty":22.122715,"marketCap":68898843},{"date":"2022-10-21","current":4.802294,"twenty":-0.299399,"median":2.878511,"eighty":22.101982,"marketCap":71237228},{"date":"2022-10-28","current":5.731225,"twenty":-0.297895,"median":2.885762,"eighty":22.101982,"marketCap":85016997},{"date":"2022-11-04","current":5.658037,"twenty":-0.294886,"median":2.890595,"eighty":22.081248,"marketCap":83931318},{"date":"2022-11-11","current":3.269547,"twenty":-0.287363,"median":2.891803,"eighty":22.060514,"marketCap":82896095},{"date":"2022-11-18","current":3.224437,"twenty":-0.28285,"median":2.893012,"eighty":22.039781,"marketCap":81752380},{"date":"2022-11-25","current":3.264743,"twenty":-0.281646,"median":2.900263,"eighty":22.039781,"marketCap":82774284},{"date":"2022-12-02","current":3.208315,"twenty":-0.278938,"median":2.909515,"eighty":22.039781,"marketCap":81343618},{"date":"2022-12-09","current":3.027746,"twenty":0.690334,"median":2.920572,"eighty":22.023194,"marketCap":76765484},{"date":"2022-12-16","current":2.937462,"twenty":1.319576,"median":2.928984,"eighty":21.985873,"marketCap":74476418},{"date":"2022-12-23","current":2.498939,"twenty":1.458571,"median":2.923052,"eighty":21.878059,"marketCap":63358094},{"date":"2022-12-30","current":2.663385,"twenty":1.56152,"median":2.918116,"eighty":21.803418,"marketCap":67527465},{"date":"2023-01-06","current":2.889096,"twenty":1.56152,"median":2.920572,"eighty":21.803418,"marketCap":73250132},{"date":"2023-01-13","current":3.121255,"twenty":1.56152,"median":2.934238,"eighty":21.803418,"marketCap":79136303},{"date":"2023-01-20","current":3.163173,"twenty":1.56152,"median":2.940687,"eighty":21.803418,"marketCap":80199084},{"date":"2023-01-27","current":3.03742,"twenty":1.56152,"median":2.963813,"eighty":21.803418,"marketCap":77010741},{"date":"2023-02-03","current":3.089011,"twenty":1.56152,"median":2.97938,"eighty":21.803418,"marketCap":78318780},{"date":"2023-02-10","current":2.995502,"twenty":1.56152,"median":2.986046,"eighty":21.803418,"marketCap":75947961},{"date":"2023-02-17","current":3.069664,"twenty":1.56152,"median":2.995967,"eighty":21.803418,"marketCap":77828265},{"date":"2023-02-24","current":3.101909,"twenty":1.56152,"median":3.006318,"eighty":21.803418,"marketCap":78645789},{"date":"2023-03-03","current":7.166438,"twenty":1.56152,"median":3.021298,"eighty":21.803418,"marketCap":76129066},{"date":"2023-03-10","current":6.673589,"twenty":1.565877,"median":3.03742,"eighty":21.803418,"marketCap":70893541},{"date":"2023-03-17","current":6.627828,"twenty":1.596379,"median":3.047969,"eighty":21.803418,"marketCap":70407414},{"date":"2023-03-24","current":7.581198,"twenty":1.601086,"median":3.061417,"eighty":21.803418,"marketCap":80535062},{"date":"2023-03-31","current":7.413404,"twenty":1.645072,"median":3.077506,"eighty":21.786831,"marketCap":78752596},{"date":"2023-04-06","current":7.192223,"twenty":1.601086,"median":3.08741,"eighty":21.803418,"marketCap":76402982},{"date":"2023-04-14","current":7.390524,"twenty":1.5571,"median":3.105133,"eighty":21.820005,"marketCap":78509533},{"date":"2023-04-21","current":7.375972,"twenty":1.513114,"median":3.121255,"eighty":21.836592,"marketCap":78354950},{"date":"2023-04-28","current":6.610326,"twenty":1.469128,"median":3.128557,"eighty":21.853179,"marketCap":70221497},{"date":"2023-05-05","current":6.094842,"twenty":1.469128,"median":3.146532,"eighty":21.853179,"marketCap":64745508},{"date":"2023-05-12","current":6.315875,"twenty":1.469128,"median":3.161027,"eighty":21.853179,"marketCap":69335675},{"date":"2023-05-19","current":6.24252,"twenty":1.469128,"median":3.171711,"eighty":21.853179,"marketCap":68530383},{"date":"2023-05-26","current":5.892774,"twenty":1.469128,"median":3.174891,"eighty":21.853179,"marketCap":64690871},{"date":"2023-06-02","current":6.111565,"twenty":1.469128,"median":3.178756,"eighty":21.853179,"marketCap":67092760},{"date":"2023-06-09","current":6.149999,"twenty":1.469128,"median":3.189323,"eighty":21.853179,"marketCap":67514692},{"date":"2023-06-16","current":6.082393,"twenty":1.469128,"median":3.199227,"eighty":21.853179,"marketCap":66772508},{"date":"2023-06-23","current":6.049574,"twenty":1.458571,"median":3.208315,"eighty":21.878059,"marketCap":66412225},{"date":"2023-06-30","current":6.257426,"twenty":1.448015,"median":3.216397,"eighty":21.902939,"marketCap":68694019},{"date":"2023-07-07","current":6.250133,"twenty":1.448015,"median":3.224292,"eighty":21.902939,"marketCap":68613956},{"date":"2023-07-14","current":6.578319,"twenty":1.448015,"median":3.243521,"eighty":21.902939,"marketCap":72216789},{"date":"2023-07-21","current":6.702301,"twenty":1.448015,"median":3.24834,"eighty":21.902939,"marketCap":73577860},{"date":"2023-07-28","current":6.578319,"twenty":1.448015,"median":3.264991,"eighty":21.902939,"marketCap":72216789},{"date":"2023-08-04","current":6.184495,"twenty":1.448015,"median":3.286333,"eighty":21.902939,"marketCap":67893390},{"date":"2023-08-11","current":6.351685,"twenty":1.448015,"median":3.322273,"eighty":21.902939,"marketCap":70535467},{"date":"2023-08-18","current":6.122833,"twenty":1.448015,"median":3.390097,"eighty":21.902939,"marketCap":67994059},{"date":"2023-08-25","current":6.050115,"twenty":1.448015,"median":3.429194,"eighty":21.902939,"marketCap":67186529},{"date":"2023-09-01","current":6.166463,"twenty":1.448015,"median":3.730203,"eighty":21.902939,"marketCap":68478577},{"date":"2023-09-08","current":5.810147,"twenty":1.448015,"median":3.743573,"eighty":21.902939,"marketCap":64521678},{"date":"2023-09-15","current":6.006485,"twenty":1.448015,"median":3.764583,"eighty":21.902939,"marketCap":66702011},{"date":"2023-09-22","current":5.868321,"twenty":1.448015,"median":4.024697,"eighty":21.902939,"marketCap":65167703},{"date":"2023-09-29","current":5.991941,"twenty":1.448015,"median":4.078921,"eighty":21.902939,"marketCap":66540504},{"date":"2023-10-06","current":5.970126,"twenty":1.448015,"median":4.113063,"eighty":21.902939,"marketCap":66298245},{"date":"2023-10-13","current":5.82469,"twenty":1.448015,"median":4.135155,"eighty":21.902939,"marketCap":64683185},{"date":"2023-10-20","current":5.263018,"twenty":1.448015,"median":4.142325,"eighty":21.902939,"marketCap":58445820},{"date":"2023-10-27","current":5.453103,"twenty":1.416345,"median":4.14118,"eighty":21.97758,"marketCap":60556704},{"date":"2023-11-03","current":5.639187,"twenty":1.416345,"median":4.14118,"eighty":14.071633,"marketCap":62623174},{"date":"2023-11-10","current":4.597236,"twenty":1.416345,"median":4.14118,"eighty":13.99376,"marketCap":60968545},{"date":"2023-11-17","current":4.691483,"twenty":1.416345,"median":4.14118,"eighty":13.99376,"marketCap":62218453},{"date":"2023-11-24","current":4.594442,"twenty":1.416345,"median":4.14118,"eighty":13.99376,"marketCap":60931496},{"date":"2023-12-01","current":4.552014,"twenty":1.416345,"median":4.14118,"eighty":13.99376,"marketCap":60368804},{"date":"2023-12-08","current":5.091467,"twenty":1.426902,"median":4.14118,"eighty":13.959496,"marketCap":67523030},{"date":"2023-12-15","current":5.430898,"twenty":1.426902,"median":4.14118,"eighty":13.959496,"marketCap":72024565},{"date":"2023-12-22","current":6.121882,"twenty":1.426902,"median":4.144334,"eighty":13.959496,"marketCap":81188405},{"date":"2023-12-29","current":5.921861,"twenty":1.416345,"median":4.173313,"eighty":13.99376,"marketCap":78535715},{"date":"2024-01-05","current":5.994596,"twenty":1.319576,"median":4.201799,"eighty":14.009335,"marketCap":79500329},{"date":"2024-01-12","current":6.030963,"twenty":1.319576,"median":4.247621,"eighty":14.009335,"marketCap":79982637},{"date":"2024-01-19","current":5.897615,"twenty":1.222807,"median":4.282189,"eighty":14.024909,"marketCap":78214176},{"date":"2024-01-26","current":5.909738,"twenty":1.319576,"median":4.311888,"eighty":14.009335,"marketCap":78374946},{"date":"2024-02-02","current":6.079454,"twenty":1.319576,"median":4.327955,"eighty":14.009335,"marketCap":80625713},{"date":"2024-02-09","current":5.976412,"twenty":1.319576,"median":4.350046,"eighty":14.009335,"marketCap":79259176},{"date":"2024-02-16","current":6.085515,"twenty":1.319576,"median":4.362096,"eighty":14.009335,"marketCap":80706098},{"date":"2024-02-23","current":6.321904,"twenty":1.319576,"median":4.386196,"eighty":14.009335,"marketCap":83841096},{"date":"2024-03-01","current":6.697703,"twenty":1.416345,"median":4.576259,"eighty":13.99376,"marketCap":88824938},{"date":"2024-03-08","current":3.802021,"twenty":1.416345,"median":4.594442,"eighty":13.99376,"marketCap":85127249},{"date":"2024-03-15","current":3.670771,"twenty":1.416345,"median":4.552014,"eighty":13.627758,"marketCap":82188558},{"date":"2024-03-22","current":4.518879,"twenty":1.416345,"median":4.374799,"eighty":13.542097,"marketCap":101177708},{"date":"2024-03-28","current":4.473036,"twenty":1.416345,"median":4.324209,"eighty":13.253968,"marketCap":100151267},{"date":"2024-04-05","current":4.548166,"twenty":1.319576,"median":4.316791,"eighty":13.048383,"marketCap":101833436},{"date":"2024-04-12","current":4.421557,"twenty":1.319576,"median":4.316791,"eighty":12.951821,"marketCap":98998672},{"date":"2024-04-19","current":4.434543,"twenty":1.319576,"median":4.316791,"eighty":12.824109,"marketCap":99289417},{"date":"2024-04-26","current":4.434543,"twenty":1.416345,"median":4.324209,"eighty":12.732219,"marketCap":99289417},{"date":"2024-05-03","current":4.212125,"twenty":1.416345,"median":4.309328,"eighty":12.514175,"marketCap":94309475},{"date":"2024-05-10","current":3.932803,"twenty":1.416345,"median":4.212125,"eighty":12.280556,"marketCap":98662220},{"date":"2024-05-17","current":3.918344,"twenty":1.416345,"median":4.14347,"eighty":12.078087,"marketCap":98299491},{"date":"2024-05-24","current":3.756405,"twenty":1.416345,"median":3.988402,"eighty":12.000214,"marketCap":94236929},{"date":"2024-05-31","current":3.606033,"twenty":1.416345,"median":3.918344,"eighty":11.314932,"marketCap":90464550},{"date":"2024-06-07","current":3.788005,"twenty":1.416345,"median":3.860508,"eighty":9.717873,"marketCap":95029691},{"date":"2024-06-14","current":3.851139,"twenty":1.319576,"median":3.804358,"eighty":7.887548,"marketCap":96613519},{"date":"2024-06-21","current":3.893228,"twenty":1.222807,"median":3.802673,"eighty":7.521707,"marketCap":97669405},{"date":"2024-06-28","current":3.839113,"twenty":0.932501,"median":3.800901,"eighty":7.413404,"marketCap":96311838},{"date":"2024-07-05","current":3.953355,"twenty":0.932501,"median":3.800901,"eighty":7.375972,"marketCap":99177812},{"date":"2024-07-12","current":4.109685,"twenty":0.932501,"median":3.800901,"eighty":7.207477,"marketCap":103099673},{"date":"2024-07-15","current":4.193863,"twenty":0.932501,"median":3.800901,"eighty":7.194036,"marketCap":105211444},{"date":"2024-08-02","current":4.458422,"twenty":-0.282248,"median":3.785593,"eighty":6.893892,"marketCap":111848438},{"date":"2024-08-09","current":4.330188,"twenty":-0.282248,"median":3.785593,"eighty":6.71397,"marketCap":112034952},{"date":"2024-08-16","current":4.293515,"twenty":-0.282248,"median":3.785593,"eighty":6.684421,"marketCap":111086122},{"date":"2024-08-23","current":4.437385,"twenty":-0.282248,"median":3.785593,"eighty":6.626684,"marketCap":114808456},{"date":"2024-08-30","current":4.443027,"twenty":-0.282248,"median":3.785593,"eighty":6.593741,"marketCap":114954430},{"date":"2024-09-06","current":4.420459,"twenty":-0.282248,"median":3.785593,"eighty":6.572485,"marketCap":114370534},{"date":"2024-09-13","current":4.358398,"twenty":-0.282248,"median":3.785593,"eighty":6.489344,"marketCap":112764822},{"date":"2024-09-20","current":4.358398,"twenty":-0.282248,"median":3.785593,"eighty":6.439122,"marketCap":112764822},{"date":"2024-09-27","current":4.403533,"twenty":-0.282248,"median":3.785593,"eighty":6.403286,"marketCap":113932613},{"date":"2024-10-04","current":4.45149,"twenty":-0.282248,"median":3.785593,"eighty":6.389947,"marketCap":115173391},{"date":"2024-10-11","current":4.474057,"twenty":-0.282248,"median":3.785593,"eighty":6.366105,"marketCap":115757286},{"date":"2024-10-18","current":4.327367,"twenty":-0.282248,"median":3.785593,"eighty":6.321904,"marketCap":111961965},{"date":"2024-10-25","current":4.321725,"twenty":-0.282248,"median":3.785593,"eighty":6.261802,"marketCap":111815992},{"date":"2024-10-31","current":4.27941,"twenty":-0.282248,"median":3.785593,"eighty":6.240491,"marketCap":110721187},{"date":"2024-11-08","current":4.441959,"twenty":-0.282549,"median":3.784012,"eighty":6.202291,"marketCap":116779104},{"date":"2024-11-15","current":4.397133,"twenty":-0.282549,"median":3.784012,"eighty":6.149605,"marketCap":115600635},{"date":"2024-11-22","current":4.560596,"twenty":-0.282549,"median":3.784012,"eighty":6.139391,"marketCap":119898057},{"date":"2024-11-29","current":4.732231,"twenty":-0.282549,"median":3.784012,"eighty":6.120618,"marketCap":124410349},{"date":"2024-12-06","current":4.80034,"twenty":-0.282549,"median":3.784012,"eighty":6.102487,"marketCap":126200941},{"date":"2024-12-13","current":4.66957,"twenty":-0.282549,"median":3.784012,"eighty":6.088852,"marketCap":122763004},{"date":"2024-12-20","current":4.171011,"twenty":-0.282549,"median":3.784012,"eighty":6.078382,"marketCap":109655869},{"date":"2024-12-27","current":4.405306,"twenty":-0.282549,"median":3.784012,"eighty":6.067331,"marketCap":115815506},{"date":"2025-01-03","current":4.489762,"twenty":-0.282549,"median":3.784012,"eighty":6.059453,"marketCap":118035841},{"date":"2025-01-10","current":4.745853,"twenty":-0.28285,"median":3.782431,"eighty":6.049147,"marketCap":124768467},{"date":"2025-01-17","current":4.822135,"twenty":-0.28285,"median":3.782431,"eighty":6.037025,"marketCap":126773931},{"date":"2025-01-24","current":4.890244,"twenty":-0.28285,"median":3.782431,"eighty":6.035572,"marketCap":128564523},{"date":"2025-01-31","current":4.794891,"twenty":-0.28285,"median":3.782431,"eighty":6.016756,"marketCap":126057694},{"date":"2025-02-07","current":5.012841,"twenty":-0.28285,"median":3.782431,"eighty":6.002169,"marketCap":131787589},{"date":"2025-02-14","current":5.165406,"twenty":-0.28285,"median":3.782431,"eighty":5.999213,"marketCap":135798516},{"date":"2025-02-21","current":5.375182,"twenty":-0.28285,"median":3.782431,"eighty":5.991941,"marketCap":141313540},{"date":"2025-02-28","current":5.6231,"twenty":-0.28285,"median":3.782431,"eighty":5.970126,"marketCap":147831296},{"date":"2025-03-07","current":5.080493,"twenty":-0.283753,"median":3.782268,"eighty":5.951081,"marketCap":148690780},{"date":"2025-03-14","current":5.481842,"twenty":-0.283753,"median":3.782268,"eighty":5.922788,"marketCap":160437065},{"date":"2025-03-21","current":11.366901,"twenty":-0.283753,"median":3.788005,"eighty":5.926495,"marketCap":332675095},{"date":"2025-03-28","current":5.041233,"twenty":-0.283753,"median":3.800901,"eighty":5.92678,"marketCap":147541761},{"date":"2025-04-04","current":4.869586,"twenty":-0.283753,"median":3.829511,"eighty":5.92678,"marketCap":142518184},{"date":"2025-04-11","current":4.150082,"twenty":-0.28285,"median":3.860508,"eighty":5.926495,"marketCap":121460451},{"date":"2025-04-17","current":4.12892,"twenty":-0.28285,"median":3.878196,"eighty":5.926495,"marketCap":120841106},{"date":"2025-04-25","current":4.180649,"twenty":-0.283753,"median":3.918344,"eighty":5.92678,"marketCap":122355061},{"date":"2025-05-02","current":5.432928,"twenty":-0.283753,"median":3.947302,"eighty":5.92678,"marketCap":128135615},{"date":"2025-05-09","current":5.37749,"twenty":-0.281646,"median":3.98112,"eighty":5.92678,"marketCap":126828109},{"date":"2025-05-16","current":5.476695,"twenty":2.250745,"median":4.028927,"eighty":5.92678,"marketCap":129167857},{"date":"2025-05-23","current":5.249107,"twenty":2.332489,"median":4.112248,"eighty":5.92678,"marketCap":123800199},{"date":"2025-05-30","current":5.567147,"twenty":2.374551,"median":4.140676,"eighty":5.92678,"marketCap":131301156},{"date":"2025-06-06","current":5.307463,"twenty":2.40471,"median":4.185579,"eighty":5.92678,"marketCap":125176522},{"date":"2025-06-13","current":5.224981,"twenty":2.416202,"median":4.205138,"eighty":5.92678,"marketCap":123231183},{"date":"2025-06-20","current":5.158476,"twenty":2.41849,"median":4.272609,"eighty":5.927066,"marketCap":121662663},{"date":"2025-06-27","current":4.984985,"twenty":2.422764,"median":4.287873,"eighty":5.927066,"marketCap":117570869},{"date":"2025-07-03","current":5.25968,"twenty":2.428519,"median":4.304505,"eighty":5.927066,"marketCap":124049542},{"date":"2025-07-11","current":5.175825,"twenty":2.4314,"median":4.313262,"eighty":5.927066,"marketCap":122071842},{"date":"2025-07-18","current":5.10932,"twenty":2.435775,"median":4.324546,"eighty":5.927066,"marketCap":120503321},{"date":"2025-07-25","current":5.476544,"twenty":2.441952,"median":4.330188,"eighty":5.927066,"marketCap":129164284},{"date":"2025-08-01","current":5.690516,"twenty":2.44528,"median":4.348095,"eighty":5.927066,"marketCap":134210830},{"date":"2025-08-08","current":12.38965,"twenty":2.450451,"median":4.358398,"eighty":5.954591,"marketCap":268558053},{"date":"2025-08-15","current":6.486713,"twenty":2.458262,"median":4.36404,"eighty":5.97264,"marketCap":140605991},{"date":"2025-08-22","current":6.679906,"twenty":2.465491,"median":4.368755,"eighty":5.994708,"marketCap":144793651},{"date":"2025-08-29","current":6.810885,"twenty":2.470572,"median":4.375842,"eighty":6.000657,"marketCap":147632742},{"date":"2025-09-05","current":6.987706,"twenty":2.483034,"median":4.398496,"eighty":6.006485,"marketCap":151465515},{"date":"2025-09-12","current":6.928766,"twenty":2.495068,"median":4.409175,"eighty":6.022625,"marketCap":150187924},{"date":"2025-09-19","current":6.941863,"twenty":2.500798,"median":4.419175,"eighty":6.035572,"marketCap":150471833},{"date":"2025-09-26","current":6.90257,"twenty":2.527324,"median":4.421557,"eighty":6.043513,"marketCap":149620106},{"date":"2025-10-03","current":6.745396,"twenty":2.532032,"median":4.434543,"eighty":6.051357,"marketCap":146213196},{"date":"2025-10-10","current":6.722474,"twenty":2.556317,"median":4.437385,"eighty":6.065728,"marketCap":145716355},{"date":"2025-10-17","current":6.643887,"twenty":2.585618,"median":4.445848,"eighty":6.0751,"marketCap":144012901},{"date":"2025-10-24","current":6.309892,"twenty":2.604655,"median":4.45149,"eighty":6.083642,"marketCap":136773218},{"date":"2025-10-31","current":6.810885,"twenty":2.630101,"median":4.459953,"eighty":6.09596,"marketCap":147632742},{"date":"2025-11-07","current":5.39737,"twenty":2.688434,"median":4.473036,"eighty":6.09596,"marketCap":154375584},{"date":"2025-11-14","current":5.219888,"twenty":2.710757,"median":4.479992,"eighty":6.09596,"marketCap":149299237},{"date":"2025-11-21","current":4.811248,"twenty":2.777321,"median":4.499446,"eighty":6.09596,"marketCap":137611319},{"date":"2025-11-28","current":5.159078,"twenty":2.84071,"median":4.527769,"eighty":6.09596,"marketCap":147559963},{"date":"2025-12-05","current":5.587177,"twenty":2.880693,"median":4.548166,"eighty":6.09596,"marketCap":159804449},{"date":"2025-12-12","current":5.764741,"twenty":2.92206,"median":4.56332,"eighty":6.09596,"marketCap":164883127},{"date":"2025-12-19","current":5.847442,"twenty":2.937055,"median":4.577383,"eighty":6.09596,"marketCap":167248539},{"date":"2025-12-26","current":5.395019,"twenty":2.947864,"median":4.593615,"eighty":6.09596,"marketCap":154308344},{"date":"2026-01-02","current":5.190699,"twenty":2.963319,"median":4.604018,"eighty":6.09596,"marketCap":148464385},{"date":"2026-01-09","current":4.996109,"twenty":2.976523,"median":4.634154,"eighty":6.09596,"marketCap":142898710},{"date":"2026-01-16","current":5.008271,"twenty":2.989785,"median":4.666846,"eighty":6.09596,"marketCap":143246565},{"date":"2026-01-23","current":4.896381,"twenty":2.995781,"median":4.677743,"eighty":6.09596,"marketCap":140046302},{"date":"2026-01-30","current":4.748006,"twenty":3.010469,"median":4.688572,"eighty":6.09596,"marketCap":135802474},{"date":"2026-02-06","current":4.349096,"twenty":3.021616,"median":4.688572,"eighty":6.09596,"marketCap":124392840},{"date":"2026-02-13","current":4.487742,"twenty":3.038658,"median":4.688572,"eighty":6.09596,"marketCap":128358384},{"date":"2026-02-20","current":4.531524,"twenty":3.047619,"median":4.688572,"eighty":6.09596,"marketCap":129610661},{"date":"2026-02-27","current":4.536389,"twenty":3.067039,"median":4.688572,"eighty":6.09596,"marketCap":129749803},{"date":"2026-03-06","current":6.263212,"twenty":3.084559,"median":4.695326,"eighty":6.105535,"marketCap":133506633},{"date":"2026-03-13","current":6.07299,"twenty":3.097394,"median":4.699538,"eighty":6.109599,"marketCap":129451860},{"date":"2026-03-20","current":6.005974,"twenty":3.114892,"median":4.71316,"eighty":6.109599,"marketCap":128023332},{"date":"2026-03-27","current":6.041078,"twenty":3.1283,"median":4.732231,"eighty":6.113163,"marketCap":128771608}],"updateTime":1774720397067},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACR\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2579452037","title":"ACRES Commercial Realty Corp. price target raised to $24.50 from $23.50 at Citizens JMP","url":"https://stock-news.laohu8.com/highlight/detail?id=2579452037","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579452037?lang=en_us&edition=fundamental","pubTime":"2025-10-31 18:05","pubTimestamp":1761905152,"startTime":"0","endTime":"0","summary":"Citizens JMP raised the firm’s price target on ACRES Commercial Realty Corp. (ACR) to $24.50 from $23.50 and keeps an Outperform rating on the shar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acres-commercial-realty-corp-price-target-raised-to-24-50-from-23-50-at-citizens-jmp-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acres-commercial-realty-corp-price-target-raised-to-24-50-from-23-50-at-citizens-jmp-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACR","JMP"],"gpt_icon":0},{"id":"1134217316","title":"ACRES Realty Q3 2025 Earnings Call Summary and Q&A Highlights: Strategic Asset Sales and Book Value Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1134217316","media":"Earnings Call","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134217316?lang=en_us&edition=fundamental","pubTime":"2025-10-30 22:56","pubTimestamp":1761836195,"startTime":"0","endTime":"0","summary":"[Management View]The management reported a net loan portfolio decrease of $46.8 million in Q3 2025, driven by $106.4 million in new loan commitments and $153.2 million in loan payoffs, sales, and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR"],"gpt_icon":0},{"id":"2579269021","title":"ACRES Realty (ACR) Earnings Call Transcript","url":"https://stock-news.laohu8.com/highlight/detail?id=2579269021","media":"Motley Fool Transcribing","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579269021?lang=en_us&edition=fundamental","pubTime":"2025-10-30 22:52","pubTimestamp":1761835945,"startTime":"0","endTime":"0","summary":"DATEThursday, October 30, 2025 at 10 a.m. ETCALL PARTICIPANTSChief Executive Officer and President — Mark Steven FogelChief Financial Officer — Eldron C. BlackwellChairman — Andrew Dodd FentressManaging Director — Kyle K. BrengelNeed a quote from a Motley Fool analyst?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_motley_transcript","url":"https://www.fool.com/earnings/call-transcripts/2025/10/30/acres-realty-acr-earnings-call-transcript/","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/earnings/call-transcripts/2025/10/30/acres-realty-acr-earnings-call-transcript/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_motley_transcript","symbols":["ACR"],"gpt_icon":0},{"id":"2579513627","title":"ACRES Commercial Realty Q3 Sales $21.037M Miss $22.151M Estimate.","url":"https://stock-news.laohu8.com/highlight/detail?id=2579513627","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579513627?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:30","pubTimestamp":1761769826,"startTime":"0","endTime":"0","summary":"ACRES Commercial Realty (NYSE:ACR) reported quarterly sales of $21.037 million which missed the analyst consensus estimate of $22.151 million by 5.03 percent. This is a 5.89 percent decrease over sales of $22.353 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/10/48512463/acres-commercial-realty-q3-sales-21-037m-miss-22-151m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ACRES Commercial Realty Q3 Sales $21.037M Miss $22.151M Estimate.","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR","BK4110"],"gpt_icon":0},{"id":"2579133748","title":"Acres Commercial Realty reports Q3 net income of $9.8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2579133748","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579133748?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:10","pubTimestamp":1761768635,"startTime":"0","endTime":"0","summary":"Acres Commercial Realty Corp. reported GAAP net income allocable to common shares of $9.8 million, or $1.34 per diluted share, for the third quarter ended September 30, 2025. During the quarter, the company sold one of its real estate investments to utilize deferred tax assets, with the proceeds redeployed into new loans. Acres Commercial Realty Corp. stated its intention to continue growing its portfolio in the fourth quarter and beyond by investing in new loan opportunities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acres Commercial Realty Corp. published the original content used to generate this news brief via PR Newswire  on October 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nNDL9BrFJT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR","BK4110"],"gpt_icon":0},{"id":"2579139159","title":"Acres Commercial Realty Corp - Reports $9.8 Mln Net Income, $1.34 per Share  for Q3","url":"https://stock-news.laohu8.com/highlight/detail?id=2579139159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579139159?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:10","pubTimestamp":1761768601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nPLX44DE1A:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4110","ACR"],"gpt_icon":0},{"id":"2579182133","title":"Acres Commercial Realty Corp. Reports Results for Third Quarter 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2579182133","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579182133?lang=en_us&edition=fundamental","pubTime":"2025-10-30 04:10","pubTimestamp":1761768600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUA9MYYGZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACR","BK4110"],"gpt_icon":0},{"id":"2579900527","title":"Novartis ianalumab first drug to reduce disease activity and patient burden in Sjögren’s disease Phase III trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2579900527","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579900527?lang=en_us&edition=fundamental","pubTime":"2025-10-29 22:30","pubTimestamp":1761748200,"startTime":"0","endTime":"0","summary":"NEPTUNUS-1 and NEPTUNUS-2 achieved primary objective of reduced disease activity and provided clinically meaningful benefit1Data showed consistentimprovementsacross secondary outcome measures, and a f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/29/3176619/0/en/Novartis-ianalumab-first-drug-to-reduce-disease-activity-and-patient-burden-in-Sj%C3%B6gren-s-disease-Phase-III-trials.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["III","SLE","ACR","BK4077","BK4199","ITP","BK4134","BK4110"],"gpt_icon":0},{"id":"2579790195","title":"Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2579790195","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579790195?lang=en_us&edition=fundamental","pubTime":"2025-10-29 21:15","pubTimestamp":1761743700,"startTime":"0","endTime":"0","summary":"New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, from Week 12 to Week 28 regardless of prior advanced thera","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/29/3176538/0/en/Anaptys-Announces-New-Positive-Phase-2b-Trial-Results-for-Rosnilimab-in-Rheumatoid-Arthritis-at-ACR-Late-Breaking-Oral-Presentation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RA","BK4110","ACR"],"gpt_icon":0},{"id":"2578951877","title":"Enlivex Therapeutics to Present Phase IIa 3-month Data of Allocetra in Patients with Moderate-to-Severe Knee Osteoarthritis at the ACR Convergence 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2578951877","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578951877?lang=en_us&edition=fundamental","pubTime":"2025-10-28 20:15","pubTimestamp":1761653700,"startTime":"0","endTime":"0","summary":"Ness-Ziona, Israel, Oct.  28, 2025  (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/28/3175403/0/en/Enlivex-Therapeutics-to-Present-Phase-IIa-3-month-Data-of-Allocetra-in-Patients-with-Moderate-to-Severe-Knee-Osteoarthritis-at-the-ACR-Convergence-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4539","BK4110","ACR","LENZ","BK4139"],"gpt_icon":0},{"id":"1170133925","title":"QYUNS-B (02509): QX002N (Lusekizumab) Phase III Clinical Trial Results for Ankylosing Spondylitis Presented at 2025 ACR Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1170133925","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170133925?lang=en_us&edition=fundamental","pubTime":"2025-10-28 17:56","pubTimestamp":1761645383,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on October 27, 2025, the Phase III clinical trial results of its self-developed drug, QX002N (Lusekizumab), for the treatment of ankylosing spondylitis (AS) were...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","III","ACR","BK4134","BK4110","02509"],"gpt_icon":0},{"id":"2578677499","title":"Acrivon Therapeutics’ Phase 1 Study of ACR-2316: Key Updates and Market Implications","url":"https://stock-news.laohu8.com/highlight/detail?id=2578677499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578677499?lang=en_us&edition=fundamental","pubTime":"2025-10-28 07:18","pubTimestamp":1761607129,"startTime":"0","endTime":"0","summary":"Acrivon Therapeutics, Inc. (($ACRV)) announced an update on their ongoing clinical study. Study Overview: Acrivon Therapeutics, Inc. is conducting ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/acrivon-therapeutics-phase-1-study-of-acr-2316-key-updates-and-market-implications?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/acrivon-therapeutics-phase-1-study-of-acr-2316-key-updates-and-market-implications?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACR","BK4539","BK4139","BK4007","BK4110","LENZ"],"gpt_icon":0},{"id":"2578064963","title":"Acres Commercial Realty Corp  expected to post earnings of 11 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2578064963","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578064963?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:44","pubTimestamp":1761569056,"startTime":"0","endTime":"0","summary":"Acres Commercial Realty Corp  expected to post earnings of11cents a share - Earnings Preview Acres Commercial Realty Corp ACR.N, ACR is expected to  show a fall in quarterly revenue when it reports  r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nL8N3W80ZV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR","BK4110"],"gpt_icon":0},{"id":"2578648653","title":"Tonix Pharmaceuticals presents data on Tonmya at ACR Convergence","url":"https://stock-news.laohu8.com/highlight/detail?id=2578648653","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578648653?lang=en_us&edition=fundamental","pubTime":"2025-10-27 19:16","pubTimestamp":1761563794,"startTime":"0","endTime":"0","summary":"Tonix Pharmaceuticals (TNXP) presented data on Tonmya, which was investigated as TNX-102 SL, at the 2025 American College of Rheumatology Convergen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tonix-pharmaceuticals-presents-data-on-tonmya-at-acr-convergence-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tonix-pharmaceuticals-presents-data-on-tonmya-at-acr-convergence-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4110","ACR","BK4583","TNXP","BK4139"],"gpt_icon":0},{"id":"2578964388","title":"Kymera Therapeutics Presents New Preclinical Data for KT-579, a First-in-Class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2578964388","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578964388?lang=en_us&edition=fundamental","pubTime":"2025-10-27 19:00","pubTimestamp":1761562800,"startTime":"0","endTime":"0","summary":"KT-579, a potent, selective, oral degrader of IRF5, demonstrated broad activity across multiple preclinical models of lupus and rheumatoid arthritis (RA), with activity comparable or superior to appro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/27/3174428/0/en/Kymera-Therapeutics-Presents-New-Preclinical-Data-for-KT-579-a-First-in-Class-Oral-IRF5-Degrader-at-the-American-College-of-Rheumatology-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYMR","BK4107","ACR","BK4110","BK4117","LU0541501648.USD","LU0541502299.USD","BK4139","IBD","BK4115","KT","AFG","RA"],"gpt_icon":0},{"id":"2578648053","title":"Tonix Pharmaceuticals Presented Data on Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence","url":"https://stock-news.laohu8.com/highlight/detail?id=2578648053","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578648053?lang=en_us&edition=fundamental","pubTime":"2025-10-27 19:00","pubTimestamp":1761562800,"startTime":"0","endTime":"0","summary":"Tonmya demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT studyTreatment was well tolerated with minimal effects on weight or blood pressure and dis","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/27/3174414/28908/en/Tonix-Pharmaceuticals-Presented-Data-on-Tonmya-Cyclobenzaprine-HCl-Sublingual-Tablets-at-the-2025-American-College-of-Rheumatology-ACR-Convergence.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4110","LU2125154935.USD","LU0029874061.USD","BK4583","CNS","ACR","BK4161","LU2125154778.USD","BK4135","HI","LU0128526141.USD","BK4117","BK4107","LU2360032135.SGD","AFG","TNXP","BK4139"],"gpt_icon":0},{"id":"2578464805","title":"Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2578464805","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578464805?lang=en_us&edition=fundamental","pubTime":"2025-10-27 19:00","pubTimestamp":1761562800,"startTime":"0","endTime":"0","summary":"– All myositis patients in the Phase 1/2 DM/ASyS cohort with sufficient follow-up who met key registrational inclusion criteria exceeded the registrational primary endpoint, demonstrating major TIS re","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/27/3174441/0/en/Cabaletta-Bio-Presents-Positive-Clinical-Data-and-Development-Updates-for-Rese-cel-at-ACR-Convergence-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","IE00B19Z4B17.USD","BK4110","IE0031619046.USD","IMNM","BK4077","SLE","CABA","CRS","IE00B66KJ199.SGD","IE00B7SZL793.SGD","BK4139","LU0963586101.USD","LU2065731478.USD","BK4006","BK4187","ACR"],"gpt_icon":0},{"id":"2578643636","title":"Antengene Presents Latest Preclinical Data of ATG-201 (CD19 x CD3 TCE) at ACR 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2578643636","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578643636?lang=en_us&edition=fundamental","pubTime":"2025-10-27 09:00","pubTimestamp":1761526800,"startTime":"0","endTime":"0","summary":"SHANGHAI and HONG KONG, Oct. 27, 2025 /PRNewswire/ -- Antengene Corporation Limited , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, today announced that the latest preclinical data of ATG-201  were presented in a Poster Presentation at the 2025 American College of Rheumatology  Annual Meeting, taking place from October 24th to October 29th in Chicago, IL, the United States. ATG-201 is a lead program developed using AnTenGager, the company's proprietary T-cell engager  platform which features \"2+1\" bivalent binding for low-expressing targets, steric hindrance masking, and proprietary CD3 sequences with fast on/off kinetics to minimize cytokine release syndrome  and enhance efficacy.In in vitro studies, ATG-201 demonstrated stronger B cell depletion activity in peripheral blood mononuclear c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/antengene-presents-latest-preclinical-data-of-atg-201-cd19-x-cd3-tce-at-acr-2025-302593957.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACR.AU","CRS.AU","CRS","BK4006","IND.AU","BK7096","IE00B7SZL793.SGD","LU2065731478.USD","BK7095","IE0031619046.USD","BK4181","BK4218","BK4187","BK4110","ACR","BK7508","IE00B19Z4B17.USD","BK4077","SLE","PK","IE00B66KJ199.SGD","LU0963586101.USD"],"gpt_icon":0},{"id":"2578865378","title":"Fate Therapeutics Presents New Clinical Data at ACR Convergence 2025 Demonstrating Immune Remodeling and Durable Responses in Patients with Systemic Lupus Erythematosus Treated with FT819 Off-the-Shelf CAR T-Cell Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2578865378","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578865378?lang=en_us&edition=fundamental","pubTime":"2025-10-26 23:30","pubTimestamp":1761492600,"startTime":"0","endTime":"0","summary":"As of a September 25, 2025 data cut-off-date, 10 patients with treatment-refractory, moderate-to-severe Systemic Lupus Erythematosus (SLE) were treated with a single dose of FT819 with less-intensive ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/26/3174247/24675/en/Fate-Therapeutics-Presents-New-Clinical-Data-at-ACR-Convergence-2025-Demonstrating-Immune-Remodeling-and-Durable-Responses-in-Patients-with-Systemic-Lupus-Erythematosus-Treated-wit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAR","FATE","ACR"],"gpt_icon":0},{"id":"2578450569","title":"Novartis showcases significant immunology advancements in ACR congress with new data in complex autoimmune diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2578450569","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578450569?lang=en_us&edition=fundamental","pubTime":"2025-10-25 23:00","pubTimestamp":1761404400,"startTime":"0","endTime":"0","summary":"Late-breaking positive Phase III data from ianalumab NEPTUNUS-1 and NEPTUNUS-2 trials in Sjgren’s disease to be presented Biomarker data informing use of investigational CAR-T cell therapy rapcabtagen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/25/3174166/0/en/Novartis-showcases-significant-immunology-advancements-in-ACR-congress-with-new-data-in-complex-autoimmune-diseases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4110","ACR"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":69,"code":"91000000","status":"200"}]}}